DK1922320T3 - Derivater af 5-pyridazinyl-1-azabicyclo[3.2.1]octan, fremstilling deraf og anvendelse deraf i terapi - Google Patents

Derivater af 5-pyridazinyl-1-azabicyclo[3.2.1]octan, fremstilling deraf og anvendelse deraf i terapi

Info

Publication number
DK1922320T3
DK1922320T3 DK06794297.9T DK06794297T DK1922320T3 DK 1922320 T3 DK1922320 T3 DK 1922320T3 DK 06794297 T DK06794297 T DK 06794297T DK 1922320 T3 DK1922320 T3 DK 1922320T3
Authority
DK
Denmark
Prior art keywords
azabicyclo
pyridazinyl
octane
therapy
derivatives
Prior art date
Application number
DK06794297.9T
Other languages
English (en)
Inventor
Frederic Galli
Odile Leclerc
Alistair W Lochead
Julien Vache
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36297201&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1922320(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1922320T3 publication Critical patent/DK1922320T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK06794297.9T 2005-08-18 2006-08-07 Derivater af 5-pyridazinyl-1-azabicyclo[3.2.1]octan, fremstilling deraf og anvendelse deraf i terapi DK1922320T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0508594A FR2889847B1 (fr) 2005-08-18 2005-08-18 Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
PCT/FR2006/001911 WO2007020343A1 (fr) 2005-08-18 2006-08-07 Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
DK1922320T3 true DK1922320T3 (da) 2011-02-21

Family

ID=36297201

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06794297.9T DK1922320T3 (da) 2005-08-18 2006-08-07 Derivater af 5-pyridazinyl-1-azabicyclo[3.2.1]octan, fremstilling deraf og anvendelse deraf i terapi

Country Status (39)

Country Link
US (3) US7476674B2 (da)
EP (1) EP1922320B1 (da)
JP (1) JP5249758B2 (da)
KR (1) KR101260546B1 (da)
CN (2) CN102558177A (da)
AR (1) AR056461A1 (da)
AT (1) ATE486073T1 (da)
AU (1) AU2006281340B2 (da)
BR (1) BRPI0614796A2 (da)
CA (1) CA2618110C (da)
CR (1) CR9693A (da)
CY (1) CY1111101T1 (da)
DE (1) DE602006017854D1 (da)
DK (1) DK1922320T3 (da)
DO (1) DOP2006000191A (da)
EA (1) EA013601B1 (da)
EC (1) ECSP088182A (da)
ES (1) ES2354833T3 (da)
FR (1) FR2889847B1 (da)
HN (1) HN2008000276A (da)
HR (1) HRP20110043T1 (da)
IL (1) IL189014A0 (da)
JO (1) JO2680B1 (da)
MA (1) MA29913B1 (da)
MX (1) MX2008002276A (da)
MY (1) MY145923A (da)
NO (1) NO20081289L (da)
NZ (1) NZ565537A (da)
PE (1) PE20070234A1 (da)
PL (1) PL1922320T3 (da)
PT (1) PT1922320E (da)
RS (1) RS51653B (da)
SI (1) SI1922320T1 (da)
TN (1) TNSN08026A1 (da)
TW (1) TWI322808B (da)
UA (1) UA92360C2 (da)
UY (1) UY29756A1 (da)
WO (1) WO2007020343A1 (da)
ZA (1) ZA200800966B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
EP3828174A4 (en) 2018-07-19 2022-08-17 Sumitomo Pharma Co., Ltd. PYRIDAZINONE DERIVATIVE
JPWO2021141041A1 (da) 2020-01-07 2021-07-15

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
US6277855B1 (en) 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
ES2223209B1 (es) 2001-12-11 2005-10-01 Esteve Quimica, S.A. Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion.
EP1358177B1 (en) 2000-10-13 2006-08-02 NeuroSearch A/S Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
US6644511B2 (en) 2002-01-11 2003-11-11 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Container for dispensing a dual phase fluid product

Also Published As

Publication number Publication date
WO2007020343A1 (fr) 2007-02-22
HRP20110043T1 (hr) 2011-02-28
CY1111101T1 (el) 2015-06-11
NZ565537A (en) 2011-04-29
IL189014A0 (en) 2008-08-07
ECSP088182A (es) 2008-03-26
FR2889847B1 (fr) 2007-10-05
NO20081289L (no) 2008-03-17
TWI322808B (en) 2010-04-01
CA2618110A1 (fr) 2007-02-22
US7476674B2 (en) 2009-01-13
KR101260546B1 (ko) 2013-05-06
UA92360C2 (en) 2010-10-25
PE20070234A1 (es) 2007-03-26
JO2680B1 (en) 2013-03-03
JP5249758B2 (ja) 2013-07-31
AR056461A1 (es) 2007-10-10
ATE486073T1 (de) 2010-11-15
US20120046298A1 (en) 2012-02-23
CN101291933A (zh) 2008-10-22
DE602006017854D1 (de) 2010-12-09
MY145923A (en) 2012-05-15
UY29756A1 (es) 2007-03-30
TW200738715A (en) 2007-10-16
US20080176855A1 (en) 2008-07-24
RS51653B (sr) 2011-10-31
ES2354833T3 (es) 2011-03-18
CN101291933B (zh) 2012-03-14
DOP2006000191A (es) 2011-11-15
EA013601B1 (ru) 2010-06-30
FR2889847A1 (fr) 2007-02-23
SI1922320T1 (sl) 2011-02-28
CR9693A (es) 2008-03-06
PT1922320E (pt) 2011-01-19
BRPI0614796A2 (pt) 2011-04-12
KR20080034468A (ko) 2008-04-21
PL1922320T3 (pl) 2011-04-29
ZA200800966B (en) 2009-04-29
US20090088440A1 (en) 2009-04-02
HN2008000276A (es) 2011-03-30
MX2008002276A (es) 2008-03-27
EP1922320A1 (fr) 2008-05-21
AU2006281340B2 (en) 2012-04-12
TNSN08026A1 (en) 2009-07-14
EA200800615A1 (ru) 2008-06-30
EP1922320B1 (fr) 2010-10-27
AU2006281340A1 (en) 2007-02-22
US8076340B2 (en) 2011-12-13
US8557819B2 (en) 2013-10-15
CN102558177A (zh) 2012-07-11
HK1125628A1 (en) 2009-08-14
JP2009504714A (ja) 2009-02-05
MA29913B1 (fr) 2008-11-03
CA2618110C (fr) 2014-02-11

Similar Documents

Publication Publication Date Title
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
NO20054905D0 (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
IL181069A0 (en) Sulphonamide derivatives , their preparation and their therapeutic application
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL191759A (en) Ganaxolone formulations and methods for the making and use thereof
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL182624A0 (en) 2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
DE602005002470D1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
DK1708994T3 (da) Aryloxyalkylcarbamatderivater, fremstilling og anvendelse herfra inden for terapi
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
IL180867A0 (en) Pyrrole derivatives, their preparation and their therapeutic use
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
PL1776340T3 (pl) Pochodne B-(1H-indolilo)-1H-indolo-2-karboksyamidów, ich wytwarzanie i zastosowanie ich w lecznictwie
DK1902054T3 (da) Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf
ZA200800966B (en) Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
IL188185A0 (en) Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
DK1742947T3 (da) 6-substituerede pyridoindolanderivater, fremstilling og terapeutisk anvendelse heraf
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
ZA200700603B (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
HK1120259A (en) Benzodiazepine derivatives, their preparation and the therapeutic use thereof